Frequent mutations of β‐catenin gene in sporadic secreting adrenocortical adenomas*
Abstract
OBJECTIVE: Molecular alterations remain largely unknown in most sporadic adrenocortical tumours and hyperplasias. In our previous work, we demonstrated the differential expression of several Wnt/beta-catenin signalling-related genes implicated in ACTH-independent macronodular adrenal hyperplasias (AIMAH). To better understand the role of Wnt/beta-catenin signalling in adrenocortical tumours, we performed mutational analysis of the beta-catenin gene. METHODS: We studied 53 human adrenocortical samples (33 adenomas, 4 carcinomas, 13 AIMAH, 3 ACTH-dependent adrenal hyperplasias) and the human adrenocortical cancer cell line NCI-H295R. All samples were screened for somatic mutations in exons 3 and 5 of the beta-catenin gene. Eleven and six samples were analysed for beta-catenin protein expression by Western blotting and immunohistochemistry, respectively. RESULTS: No mutations were detected in adrenocortical carcinomas, AIMAH and ACTH-dependent hyperplasias. Genetic alterations were found in 5 (15%) out of 33 adenomas: three cortisol-secreting adenomas, one aldosterone-secreting adenoma and one nonfunctional adenoma. Two-point mutations occurred at serine residues of codons 37 and 45 (S37C and S45F). The remaining three tumours contained deletions of 6, 55 and 271 bp. H295R cells carry an activating S45P mutation. Western blot analysis of samples with 55- and 271-bp deletions showed an additional shorter and more intense band representing an accumulation of the mutated form of beta-catenin protein. In addition, cytoplasmic and/or nuclear accumulation of beta-catenin was observed in mutated adenomas by immunohistochemistry. CONCLUSIONS: Activating mutations of exon 3 of the beta-catenin gene are frequent in adrenocortical adenomas, and further characterization of the Wnt/beta-catenin signalling pathway should lead to a better understanding of adrenal tumourigenesis.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Activating point mutations in CTNNB1 are identified in over 25% of both ACAs and ACCs in children and adults.
“mutational analysis of the effector of the canonical Wnt pathway, the β-catenin gene, CTNNB1, has identified activating point mutations in over 25% of both ACAs and ACCs in children and adults (149, 206–208).”
From Adrenocortical carcinoma (2014) · cites this paper as [208]
Mutational analysis of CTNNB1 identified activating point mutations in both ACAs and ACCs.
“Furthermore, mutational analysis of the β-catenin gene CTNNB1 identified activating point mutations in both ACAs and ACCs (149, 206–208).”
From Adrenocortical carcinoma (2014) · cites this paper as [208]
Cites
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4
LAEMMLI, U. K. (1970) · Nature · doi:10.1038/227680a0 · Cited by 249,961 · see citing works
Towbin, H., Staehelin, T., & Gordon, J. (1979) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.76.9.4350 · Cited by 51,421 · see citing works
Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii
Voth, D. E., & Heinzen, R. A. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2007.00901.x · Cited by 11,773 · see citing works
Identification of c- <i>MYC</i> as a Target of the APC Pathway
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T., Morin, P. J., Vogelstein, B., & Kinzler, K. W. (1998) · Science · doi:10.1126/science.281.5382.1509 · Cited by 4,566 · see citing works
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
Morin, P. J., Sparks, A. B., Kořínek, V., Barker, N., Clevers, H. C., Vogelstein, B., & Kinzler, K. W. (1997) · Science · doi:10.1126/science.275.5307.1787 · Cited by 3,983 · see citing works
Wnt signalling in stem cells and cancer
Reya, T., & Clevers, H. (2005) · Nature · doi:10.1038/nature03319 · Cited by 3,666 · see citing works
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
Tetsu, O., & McCormick, F. (1999) · Nature · doi:10.1038/18884 · Cited by 3,601 · see citing works
Polakis, P. (2000) · Genes & Development · doi:10.1101/gad.14.15.1837 · Cited by 3,183 · see citing works
WNT and β-catenin signalling: diseases and therapies
Moon, R. T., Kohn, A. D., Ferrari, G. V. D., & Kaykas, A. (2004) · Nature Reviews Genetics · doi:10.1038/nrg1427 · Cited by 1,763 · see citing works
The many ways of Wnt in cancer.
Polakis, P. (2007) · Current Opinion in Genetics and Development · doi:10.1016/j.gde.2006.12.007 · Cited by 961 · see citing works
Wnt signaling in the intestinal epithelium: from endoderm to cancerPreprint
Gregorieff, A., & Clevers, H. C. (2005) · Genes & Development · doi:10.1101/gad.1295405 · Cited by 673 · see citing works
β-Catenin destruction complex: insights and questions from a structural perspective
Kimelman, D., & Xu, W. (2006) · Oncogene · doi:10.1038/sj.onc.1210055 · Cited by 628 · see citing works
β-Catenin mutations in cell lines established from human colorectal cancers
Ilyas, M., Tomlinson, I. P. M., Rowan, A., Pignatelli, M. N., & Bodmer, W. F. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.19.10330 · Cited by 494 · see citing works
Tissier, F., Cavard, C., Groussin, L., Perlemoine, K., Fumey, G., Hagneré, A.-M., René-Corail, F., Jullian, E., Gicquel, C., Bertagna, X., et al. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0593 · Cited by 474 · see citing works
Management of patients with adrenal cancer: recommendations of an international consensus conference
Schteingart, D. E., Doherty, G. M., Gauger, P. G., Giordano, T. J., Hammer, G. D., Korobkin, M., & Worden, F. P. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.01029 · Cited by 421 · see citing works
Koch, A., Denkhaus, D., Albrecht, S., Leuschner, I., von Schweinitz, D., & Pietsch, T. (1999) · PubMed · Cited by 399 · see citing works
Hsu, H., Jeng, Y., Mao, T., Chu, J., Lai, P., & Peng, S. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64590-7 · Cited by 294 · see citing works
Tumor formation by genetic mutations in the components of the Wnt signaling pathway
Kikuchi, A. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01424.x · Cited by 258 · see citing works
Diverse mechanisms of beta-catenin deregulation in ovarian endometrioid adenocarcinomas.
WU, R. T., Zhai, Y., Fearon, E. R., & Cho, K. R. (2001) · PubMed · Cited by 256 · see citing works
The links between axin and carcinogenesis
Salahshor, S., & Woodgett, J. R. (2005) · Journal of Clinical Pathology · doi:10.1136/jcp.2003.009506 · Cited by 250 · see citing works
The Wnt connection to tumorigenesis
Behrens, J., & Lustig, B. (2004) · The International Journal of Developmental Biology · doi:10.1387/ijdb.041815jb · Cited by 194 · see citing works
Bourdeau, I., Antonini, S. R. R., Lacroix, A., Kirschner, L. S., Matyakhina, L., Lorang, D., Libutti, S. K., & Stratakis, C. A. (2004) · Oncogene · doi:10.1038/sj.onc.1207277 · Cited by 130 · see citing works
Self-citationAdrenal masses in patients with familial adenomatous polyposis
Marchesa, P., Fazio, V. W., Church, J. M., & McGannon, E. A. (1997) · Diseases of the Colon & Rectum · doi:10.1007/bf02050923 · Cited by 113 · see citing works
Characterisation of the phosphorylation of β-catenin at the GSK-3 priming site Ser45
Hagen, T., & Vidal‐Puig, A. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00485-0 · Cited by 110 · see citing works
Mutations of the β‐Catenin Gene in Endometrial Carcinomas
Kobayashi, K., Sagae, S., Nishioka, Y., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00665.x · Cited by 98 · see citing works
Adrenal masses are associated with familial adenomatous polyposis
Smith, T. G. P. J., Clark, S. K., Katz, D. E., Reznek, R. H., & Phillips, R. K. S. (2000) · Diseases of the Colon & Rectum · doi:10.1007/bf02236860 · Cited by 94 · see citing works
Sagae, S., Kobayashi, K., Nishioka, Y., et al. (1999) · Japanese Journal of Cancer Research · doi:10.1111/j.1349-7006.1999.tb00777.x · Cited by 72 · see citing works
Genetics of adrenocortical tumors: gatekeepers, landscapers and conductors in symphony
Stratakis, C. A. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.005 · Cited by 50 · see citing works
Wakatsuki, S., Sasano, H., Matsui, T., Nagashima, K., Toyota, T., & Horii, A. (1998) · Human Pathology · doi:10.1016/s0046-8177(98)90052-1 · Cited by 49 · see citing works
Kartheuser, A. H., Walon, C., West, S. L., Breukel, C., Detry, R. J., Gribomont, A.-C., Hamzehloei, T., Hoang, P., Maiter, D. M., Pringot, J., et al. (1999) · Journal of Medical Genetics · doi:10.1136/jmg.36.1.65 · Cited by 29 · see citing works
Clinical and Molecular Genetic Studies of Bilateral Adrenal Hyperplasias
Bourdeau, I. (2004) · Endocrine Research · doi:10.1081/erc-200043735 · Cited by 17 · see citing works
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Else, T., Kim, A. C., Sabolch, A., Raymond, V. M., Kandathil, A., Caoili, E. M., Jolly, S., Miller, B. S., Giordano, T. J., & Hammer, G. D. (2014) · Endocrine Reviews · doi:10.1210/er.2013-1029 · Cited by 892 · see citing works
Scholl, U. I., Goh, G., Stölting, G., de Oliveira, R. C., Choi, M., Overton, J. D., Fonseca, A. L., Korah, R., Starker, L. F., Kunstman, J. W., et al. (2013) · Nature Genetics · doi:10.1038/ng.2695 · Cited by 627 · see citing works
Adrenocortical carcinoma: a clinician’s update
Fassnacht, M., Libé, R., Kroiss, M., & Allolio, B. (2011) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.235 · Cited by 396 · see citing works
Development of adrenal cortex zonation
Xing, Y., Lerario, A. M., Rainey, W., & Hammer, G. D. (2015) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2015.02.001 · Cited by 174 · see citing works
Heaton, J. H., Wood, M. A., Kim, A. C., Lima, L. O., Barlaskar, F. M., Almeida, M. Q., Fragoso, M. C. B. V., Kuick, R., Lerario, A. M., Simon, D. P., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2012.05.026 · Cited by 173 · see citing works
Ragazzon, B., Libé, R., Gaujoux, S., Assié, G., Fratticci, A., Launay, P., Clauser, E., Bertagna, X., Tissier, F., de Reyniès, A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2014 · Cited by 152 · see citing works
Gaujoux, S., Grabar, S., Fassnacht, M., Ragazzon, B., Launay, P., Libé, R., Chokri, I., Audebourg, A., Royer, B., Sbiera, S., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2006 · Cited by 146 · see citing works
Gaujoux, S., Tissier, F., Groussin, L., Libé, R., Ragazzon, B., Launay, P., Audebourg, A., Dousset, B., Bertagna, X., & Bertherat, J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2008-0631 · Cited by 142 · see citing works
The Wnt/beta-catenin pathway in adrenocortical development and cancer
El Wakil, A., & Lalli, E. (2011) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2010.11.014 · Cited by 134 · see citing works
Bonnet, S., Gaujoux, S., Launay, P., Baudry, C., Chokri, I., Ragazzon, B., Libé, R., René-Corail, F., Audebourg, A., Vacher-Lavenu, M.-C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1885 · Cited by 133 · see citing works
Wnt/β-catenin signalling in adrenal physiology and tumour development
Berthon, A., Martinez, A., Bertherat, J., & Val, P. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2011.09.009 · Cited by 125 · see citing works
Detection of somatic β-catenin mutations in primary pigmented nodular adrenocortical disease (PPNAD)
Tadjine, M., Lampron, A., Ouadi, L., Horvath, A., Stratakis, C. A., & Bourdeau, I. (2008) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2008.03273.x · Cited by 108 · see citing works
Self-citationGenetic landscape of sporadic unilateral adrenocortical adenomas without PRKACA p.Leu206Arg mutation
Ronchi, C. L., Di Dalmazi, G., Faillot, S., Sbiera, S., Assié, G., Weigand, I., Calebiro, D., Schwarzmayr, T., Appenzeller, S., Rubin, B., et al. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-1586 · Cited by 93 · see citing works
Wnt/β-catenin pathway deregulation in childhood adrenocortical tumors
Leal, L. F., Mermejo, L. M., Ramalho, L. Z., Martinelli, C. E., Yunes, J. A., Seidinger, A. L., Mastellaro, M. J., Cardinalli, I. A., Brandalise, S. R., Moreira, A. C., et al. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0363 · Cited by 55 · see citing works
Investigation of BRAFand CTNNB1 activating mutations in adrenocortical tumors
Masi, G., Lavezzo, E., Iacobone, M., Favia, G., Palù, G., & Barzon, L. (2009) · Journal of Endocrinological Investigation · doi:10.1007/bf03346515 · Cited by 29 · see citing works
Identification of Genetic Alterations of<i>AXIN2</i>Gene in Adrenocortical Tumors
Chapman, A., Durand, J., Ouadi, L., & Bourdeau, I. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-2987 · Cited by 28 · see citing works
Self-citation
- Authors
- Tadjine, M., Lampron, A., Ouadi, L., & Bourdeau, I.
- Affiliations
- Centre Hospitalier de l’Université de Montréal (CA)
- Corresponding author
- Bourdeau, Isabelle
- Venue
- Clinical Endocrinology
- Publisher
- Wiley
- Published
- 2007-08-09
- Volume
- 68
- Issue
- 2
- Pages
- 264-270
- ISSN
- 0300-0664 (ISSN-L)
- 1365-2265
- OpenAlex
- W1984771998
- Cited by
- 153
- References
- 31
- Citations by year
- 2026: 7 · 2025: 3 · 2024: 2 · 2023: 5 · 2022: 6 · 2021: 6 · 2020: 7 · 2019: 9 · 2018: 3 · 2017: 10 · 2016: 14 · 2015: 11 · 2014: 11 · 2013: 10 · 2012: 6
- FWCI
- 9.96
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Adrenal and Paraganglionic Tumors
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Wnt/β-catenin signaling in development and cancer
- Keywords
- β-catenin, somatic mutations, adrenal adenoma, Wnt/β-catenin signaling, activating mutations, adrenal hyperplasia, adrenocortical carcinoma
- MeSH terms
- DNA Mutational Analysis, Humans, Immunohistochemistry, Mutation, Adrenocortical Adenoma, Reverse Transcriptase Polymerase Chain Reaction, beta Catenin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
